These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38189861)

  • 1. [Reference evaluations for estimating prevalence, incidence, and mortality of public health relevant diseases based on routine data].
    Krause L; Reitzle L; Hess S; Ziese T; Adewuyi D
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2024 Feb; 67(2):139-148. PubMed ID: 38189861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National public health system responses to diabetes and other important noncommunicable diseases : Background, goals, and results of an international workshop at the Robert Koch Institute.
    Reitzle L; Hansen S; Paprott R; Achtermann W; Baumert J; Bogaert P; Curt L; Diem P; Du Y; Eiser S; Fitzpatrick J; Heidemann C; Jousilahti P; Kulzer B; Lindström J; Neuhauser H; van Oyen H; Pelletier L; Schmidt C; Valabhji J; Weitgasser R; Ziese T; Zahn D; Scheidt-Nave C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Oct; 61(10):1300-1306. PubMed ID: 30191268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Health Promotion and Prevention of Non-Communicable Diseases by Public Health Departments in Baden-Württemberg during the COVID-19 Pandemic: Results of an Online Survey].
    Siegel A; Hesmert D; Mangold J; Klein A; Häske D; Wössner S; Rieger MA; Joos S; Mahler C
    Gesundheitswesen; 2024 Jun; 86(6):404-411. PubMed ID: 38467149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of Noncommunicable Disease Epidemic Through the Integrated Noncommunicable Disease Collaborative Management System: Feasibility Pilot Study Conducted in the City of Ningbo, China.
    Li S; Zhang L; Liu S; Hubbard R; Li H
    J Med Internet Res; 2020 Jul; 22(7):e17340. PubMed ID: 32706706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The current situation and agendas in the prevention and control of non-communicable diseases in Vietnam].
    Hattori K; Uda H; Hitomi Y; Yano R; Saijo T; Watanabe N; Satomi M; Yoshida A; Oishi O; Yamashita T; Kamenosono A
    Nihon Koshu Eisei Zasshi; 2018; 65(4):170-178. PubMed ID: 29731483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of vaccination coverage and disease incidence using statutory health insurance data].
    Reuss A; Feig M; Kappelmayer L; Eckmanns T; Poggensee G
    Gesundheitswesen; 2010 Jun; 72(6):340-6. PubMed ID: 20446216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment on the capacity for prevention and control programs for chronic non-communicable diseases in China, in 2014].
    Si X; Zhai Y; Zhu XL; Ma JX
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Feb; 40(2):231-236. PubMed ID: 30744278
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence, incidence and mortality of diabetes mellitus in adults in Germany - A review in the framework of the Diabetes Surveillance.
    Heidemann C; Scheidt-Nave C
    J Health Monit; 2017 Oct; 2(3):98-121. PubMed ID: 37168946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Utilizing Routine Health Insurance Data for Calculation of Disease Frequencies in the Project BURDEN 2020].
    Schüssel K; Breitkreuz J; Brückner G; Schröder H
    Gesundheitswesen; 2023 Mar; 85(S 02):S101-S110. PubMed ID: 35738301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Promoting Schools in Germany. Mapping the Implementation of Holistic Strategies to Tackle NCDs and Promote Health.
    Dadaczynski K; Hering T
    Int J Environ Res Public Health; 2021 Mar; 18(5):. PubMed ID: 33807890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure.
    Buse K; Tanaka S; Hawkes S
    Global Health; 2017 Jun; 13(1):34. PubMed ID: 28619031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world data for precision public health of noncommunicable diseases: a scoping review.
    Canfell OJ; Kodiyattu Z; Eakin E; Burton-Jones A; Wong I; Macaulay C; Sullivan C
    BMC Public Health; 2022 Nov; 22(1):2166. PubMed ID: 36434553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated, cross-sectoral psycho-oncology (isPO): a new form of care for newly diagnosed cancer patients in Germany.
    Kusch M; Labouvie H; Schiewer V; Talalaev N; Cwik JC; Bussmann S; Vaganian L; Gerlach AL; Dresen A; Cecon N; Salm S; Krieger T; Pfaff H; Lemmen C; Derendorf L; Stock S; Samel C; Hagemeier A; Hellmich M; Leicher B; Hültenschmidt G; Swoboda J; Haas P; Arning A; Göttel A; Schwickerath K; Graeven U; Houwaart S; Kerek-Bodden H; Krebs S; Muth C; Hecker C; Reiser M; Mauch C; Benner J; Schmidt G; Karlowsky C; Vimalanandan G; Matyschik L; Galonska L; Francke A; Osborne K; Nestle U; Bäumer M; Schmitz K; Wolf J; Hallek M
    BMC Health Serv Res; 2022 Apr; 22(1):543. PubMed ID: 35459202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining Key Influences on Patient Ability to Successfully Manage Noncommunicable Disease After Natural Disaster.
    Ryan BJ; Franklin RC; Burkle FM; Smith EC; Aitken P; Leggat PA
    Prehosp Disaster Med; 2019 Jun; 34(3):241-250. PubMed ID: 31079592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Integration of secondary data into national diabetes surveillance : Background, aims and results of the secondary data workshop at the Robert Koch Institute].
    Schmidt C; Bätzing-Feigenbaum J; Bestmann A; Brinks R; Dreß J; Goffrier B; Hagen B; Laux G; Pollmanns J; Schröder H; Stahl T; Baumert J; Du Y; Gabrys L; Heidemann C; Paprott R; Scheidt-Nave C; Teti A; Ziese T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Jun; 60(6):656-661. PubMed ID: 28466131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SurvNet@RKI--a multistate electronic reporting system for communicable diseases.
    Faensen D; Claus H; Benzler J; Ammon A; Pfoch T; Breuer T; Krause G
    Euro Surveill; 2006; 11(4):100-3. PubMed ID: 16645245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Implementing the strategy of 'Healthy China' and strengthening the setting-up of National Demonstration Areas, for Comprehensive Prevention and Control of Non-communicable Diseases].
    Jiang Y; Kong LZ; Li LM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Apr; 39(4):391-393. PubMed ID: 29699024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the effectiveness of implementation: the National Demonstration Areas for Comprehensive Prevention and Control of Non-communicable Diseases].
    Zhang J; Jin RR; Li JJ; Li JL; Su XW; Deng GJ; Ma S; Zhao J; Wang YP; Bian F; Qu YM; Shen ZZ; Jiang Y; Liu YL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Apr; 39(4):394-400. PubMed ID: 29699025
    [No Abstract]   [Full Text] [Related]  

  • 20. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.